Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Barry Borlaug MD

Barry A. Borlaug MD

Associate Professor of Medicine; Director, Circulatory Failure Research, Mayo Clinic, Rochester, Minnesota

Dr. Borlaug is a board certified cardiologist, specializing in heart failure and invasive hemodynamic assessment, where he cares for heart failure patients on a regular basis in both the clinics and hospital. He has conducted and collaborated on a number of studies examining the mechanisms of exercise tolerance using both invasive and noninvasive methods in patients with heart failure and is keenly interested in the pathophysiologic underpinnings for exercise tolerance and fatigue in heart failure. 

Recent Contributions to PracticeUpdate:

  1. Rate-Adaptive Atrial Pacing in Patients With HFpEF and Chronotropic Incompetence
  2. Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic HFrEF
  3. Prevalence and Prognostic Significance of Microvascular Dysfunction in HFpEF
  4. β-Blocker Withdrawal May Improve Functional Capacity in Heart Failure and Preserved Ejection Fraction
  5. Effect of Empagliflozin on Worsening Heart Failure Events in Patients With HFpEF
  6. Exercise-Stress Real-Time CMR Imaging for Noninvasive Characterization of HFpEF
  7. Application of Diagnostic Algorithms for HFpEF to the Community
  8. Gender-Related Differences in HFpEF
  9. The Hemodynamic Basis of Lung Congestion During Exercise in Patients With HFpEF
  10. HFpEF Infrequently Evolves Toward a Reduced Phenotype in Long-Term Survivors

Most Read This Week

Recently Updated